Routine use of gemtuzumab ozogamicin in 7 + 3-based inductions for all 'non-adverse' risk AML. Issue 6 (12th May 2021)

Record Type:
Journal Article
Title:
Routine use of gemtuzumab ozogamicin in 7 + 3-based inductions for all 'non-adverse' risk AML. Issue 6 (12th May 2021)
Main Title:
Routine use of gemtuzumab ozogamicin in 7 + 3-based inductions for all 'non-adverse' risk AML
Authors:
Ladha, Abdullah
Hui, Gavin
Cheung, Edna
Berube, Caroline
Coutre, Steven E.
Gotlib, Jason
Liedtke, Michaela
Zhang, Tian Y.
Muffly, Lori
Mannis, Gabriel N.
Abstract:
Is Part Of:
Leukemia & lymphoma. Volume 62:Issue 6(2021)
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 6(2021)
Issue Display:
Volume 62, Issue 6 (2021)
Year:
2021
Volume:
62
Issue:
6
Issue Sort Value:
2021-0062-0006-0000
Page Start:
1510
Page End:
1513
Publication Date:
2021-05-12
Subjects:
Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:
http://informahealthcare.com ↗
DOI:
10.1080/10428194.2021.1876869 ↗
Languages:
English
ISSNs:
1042-8194
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
25812.xml